Latest biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

IDP Pharma starts clinical trials of its first-in-class IDP-121 drug in hematological cancers and opens a financing round of €1M for the first phase of the study

by Parc Científic de Barcelona

10 months ago
IDP Pharma, IDP-121, multiple myeloma

The Spanish Agency of Medicines and Medical Devices has authorised the clinical trial of IDP-121, the first drug blocking and degrading a key oncoprotein in several hematological tumors, including mul...

They identify a new oncogenic and treatable fusion in aggressive hematological tumors

by Universidad Autónoma de Madrid

10 months ago
T-cell acute lymphoblastic leukemia (T-ALL), SEPTIN6::ABL2, tyrosine kinase inhibitors

The researchers demonstrate that the SEPTIN6::ABL2 fusion gene induces both the proliferation and survival of different hematopoietic cell models, behaving as an oncogenic fusion gene and contributing...

‘Traffic control’ system for mucin and insulin secretion identified

by Centre for Genomic Regulation

10 months ago
mucin, insulism, syntaxin-2, tetraspanin-8

Researchers from the Centre for Genomic Regulation (CRG) in Barcelona have published a study in the journal Nature Communications that reveals how cells carry out the controlled release of mucins and ...

3.2 million euros to identify new genetic variants responsible for hereditary cancers

by IDIBELL - Institut d’Investigació Biomèdica de Bellvitge

10 months ago
IMPaCT_VUSCan, hereditary cancers

The project will carefully examine the genetic information, gene expression patterns and DNA modifications (epigenetics) of 300 families in Spain selected for having a high-risk family or personal his...

Descubren nuevas funciones del succinato al identificarlo como biomarcador no invasivo para predecir y diagnosticar la enfermedad del hígado graso no alcohólico y como protector de las células hepáticas

by Institut d'Investigació Sanitària Pere Virgili (IISPV)

10 months ago
succinato, enfermedad del hígado graso no alcohólico, SUCNR1

Han permitido identificar el succinato como nuevo biomarcador presente en la sangre para predecir la enfermedad del hígado graso no alcohólico y para confirmar su diagnóstico. Además, este estudio...

OncoDNA Announces the Closing of a Round C financing of 6,5 M€

by OncoDNA

10 months ago
ONCODNA

OncoDNA, a genomic and theranostic company specializing in precision medicine for the treatment of patients with cancer and genetic diseases, today announced the closing of a Round C financing of 6,5 ...

El impacto del Alzheimer en mujeres

by Fundación Pasqual Maragall

10 months ago
proteína tau, Alzheimer

Según la americana Alzheimer’s Association, dos de cada tres personas diagnosticadas en Estados Unidos son mujeres, dato extrapolable a nivel mundial con pequeñas variaciones. Este mayor impacto d...

Estudian el impacto de los residuos de plaguicidas en las abejas

by Universidad Politécnica de Madrid

10 months ago
polinizadores, plaguicidas

Han evaluado el riesgo de exposición a las mezclas de plaguicidas en diferentes especies de abejas. Como resultado, realizan distintas recomendaciones para apoyar la salud de los polinizadores y el b...

Una terapia CAR-T para tratar la miastenia gravis

by Revista Genética Médica

10 months ago
miastenia gravis, Terapia CAR-T

Un estudio publicado en The Lancet Neurology plantea una terapia CAR-T con linfocitos modificados como nuevo tratamiento para una enfermedad autoinmune con resultados preliminares muy prometedores.

A boost to the UAB gene therapy study to stop the progression of neurodegenerative diseases

by Universitat Autònoma de Barcelona (UAB)

10 months ago
Klotho protein, Anew Medical, neurodegenerative diseases

La terapia génica patentada por investigadores de la UAB protege, en ratones, contra los déficits cognitivos asociados al envejecimiento, mejora la función motora y retrasa la aparición de enferme...

The biggest ever Spanish project to identify cancer risk genes kicks off

by CNIO - Centro Nacional de Investigaciones Oncológicas

10 months ago
IMPaCT_VUSCan

The first beneficiaries of this project will be families with high-risk genes that are passed down from parents to children, presenting therefore more cases of cancer than usual. IMPaCT_VUSCan will co...

Vall d'Hebron participates in the study that finds the first genetic variant related to the progression of multiple sclerosis

by Vall d’Hebron

10 months ago
multiple sclerosis disability, DYSF and ZNF638 genes

In this international study, focused on the study of the progression of multiple sclerosis disability, certain variants in the genome were compared with the evolution of 22,000 patients. In this way, ...